MedTrace Logo

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

NCT00002823 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 3300

Last updated 2013-03-28

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if combination chemotherapy given after surgery is more effective than surgery alone for non-small cell lung cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy following surgery with that of surgery alone in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer.

Conditions

Interventions

DRUG

cisplatin

DRUG

etoposide

DRUG

vinblastine sulfate

DRUG

vindesine

DRUG

vinorelbine tartrate

RADIATION

radiation therapy

Sponsors & Collaborators

  • Gustave Roussy, Cancer Campus, Grand Paris

    lead OTHER

Principal Investigators

  • Thierry L. Le Chevalier, MD · Gustave Roussy, Cancer Campus, Grand Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-02-28
Primary Completion
2001-01-31

Countries

  • United States
  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Chile
  • Colombia
  • Czechia
  • Egypt
  • Federal Republic of Yugoslavia
  • France
  • Greece
  • Israel
  • Italy
  • Japan
  • Lithuania
  • Morocco
  • North Macedonia
  • Norway
  • Philippines
  • Poland
  • Portugal
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Tunisia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002823 on ClinicalTrials.gov